Besides, Hes1 is known to directly suppress Gli1 transcription, therefore upregulating CyclinD1, suggesting that targeting Notch1 and Gli1 pathways simultaneously may be more effective to eliminate GBM cells [31]. Here, NOTCH1 is linked to glioblastoma.